Non-melanoma skin cancer (NMSC)
Clinical trials for Non-melanoma skin cancer (NMSC) explained in plain language.
Never miss a new study
Get alerted when new Non-melanoma skin cancer (NMSC) trials appear
Sign up with your email to follow new studies for Non-melanoma skin cancer (NMSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could existing cancer drugs tackle rare tumors? new trial aims to find out
Disease control Recruiting nowThis trial tests whether two approved drugs, dabrafenib and trametinib, can treat rare cancers that have a specific genetic change called BRAF V600. These drugs are already used for melanoma and lung cancer, but researchers want to see if they help people with other cancer types.…
Matched conditions: NON-MELANOMA SKIN CANCER (NMSC)
Phase 2/3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Vitamin B3 pill may shield CLL patients from skin cancer
Disease control Recruiting nowThis study tests whether taking nicotinamide (a form of vitamin B3) twice daily for one year can reduce the number of new non-melanoma skin cancers in people with chronic lymphocytic leukemia (CLL) who have already had at least one such skin cancer. About 86 participants will be …
Matched conditions: NON-MELANOMA SKIN CANCER (NMSC)
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New light device could spot skin cancer without cutting
Diagnosis Recruiting nowThis study is testing a device that shines a special light on skin growths to see if they are cancerous or harmless. The device looks for low oxygen levels, which can be a sign of cancer. Researchers will compare the device's results with standard biopsy results in 125 adults who…
Matched conditions: NON-MELANOMA SKIN CANCER (NMSC)
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC